MicroRNA‐132‐3p inhibits tumor malignant progression by regulating lysosomal‐associated protein transmembrane 4 beta in breast cancer
出版年份 2019 全文链接
标题
MicroRNA‐132‐3p inhibits tumor malignant progression by regulating lysosomal‐associated protein transmembrane 4 beta in breast cancer
作者
关键词
-
出版物
CANCER SCIENCE
Volume 110, Issue 10, Pages 3098-3109
出版商
Wiley
发表日期
2019-08-07
DOI
10.1111/cas.14164
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The Transcription Factor AP4 Promotes Oncogenic Phenotypes and Cisplatin Resistance by RegulatingLAPTM4BExpression
- (2018) Lu Wang et al. MOLECULAR CANCER RESEARCH
- AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity
- (2018) Yue Meng et al. Molecular Oncology
- A step-by-step microRNA guide to cancer development and metastasis
- (2017) Georgios S. Markopoulos et al. CELLULAR ONCOLOGY
- Transforming growth factor-β1 promotes breast cancer metastasis by downregulating miR-196a-3p expression
- (2017) Yan Chen et al. Oncotarget
- Aberrant Expression of Breast Development-Related MicroRNAs, miR-22, miR-132, and miR-212, in Breast Tumor Tissues
- (2016) Zahra Damavandi et al. Journal of Breast Cancer
- The role of microRNA-27a/b and microRNA-494 in estrogen-mediated downregulation of tissue factor pathway inhibitor α
- (2016) H. O. Ali et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Novel miRNA genes hypermethylated in breast cancer
- (2016) V. I. Loginov et al. MOLECULAR BIOLOGY
- MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4
- (2016) Weiwei Fu et al. PROSTATE
- MiR-501-5p regulates CYLD expression and promotes cell proliferation in human hepatocellular carcinoma
- (2015) De-Hao Huang et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells
- (2015) Seong-Lan Yu et al. MOLECULAR CARCINOGENESIS
- miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression
- (2015) Hongtuan Zhang et al. Oncotarget
- Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum
- (2014) Marek Sochor et al. BMC CANCER
- Breast cancer in China
- (2014) Lei Fan et al. LANCET ONCOLOGY
- MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression
- (2014) Yu Hu et al. PLoS One
- Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition
- (2014) Claudia Cava et al. PLoS One
- Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors
- (2013) Andliena Tahiri et al. CARCINOGENESIS
- Overexpression of LAPTM4B: an independent prognostic marker in breast cancer
- (2013) Min Xiao et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Loss of microRNA-132 predicts poor prognosis in patients with primary osteosarcoma
- (2013) Jie Yang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation
- (2013) Shuai Li et al. PATHOLOGY RESEARCH AND PRACTICE
- cAMP Responsive Element Binding Protein-1 Is a Transcription Factor of Lysosomal-Associated Protein Transmembrane-4 beta in Human Breast Cancer Cells
- (2013) Meng Zhang et al. PLoS One
- Overexpression of LAPTM4B-35 is associated with poor prognosis in colorectal carcinoma
- (2012) Yue Kang et al. AMERICAN JOURNAL OF SURGERY
- Association of LAPTM4B gene polymorphism with breast cancer susceptibility
- (2012) Meirong Fan et al. Cancer Epidemiology
- MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function
- (2012) B. H. Miller et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells
- (2011) Li Zhou et al. SURGERY
- LAPTM4B-35 Overexpression Is an Independent Prognostic Marker in Endometrial Carcinoma
- (2010) Fan-ling Meng et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
- (2010) Yang Li et al. NATURE MEDICINE
- MicroRNA-132–mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis
- (2010) Sudarshan Anand et al. NATURE MEDICINE
- LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling
- (2010) L Li et al. ONCOGENE
- LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells
- (2009) Xinrong Liu et al. CANCER SCIENCE
- Boosting the Brain's Ability to Block Inflammation via MicroRNA-132
- (2009) Luke A.J. O'Neill IMMUNITY
- LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma
- (2009) Hua Yang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started